Center-Authored Papers

Filters: Author is Shaw, George M  [Clear All Filters]
2008
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT et al..  2008.  Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.. Journal of virology. 82(24):12449-63. Abstract
2009
Gray ES, Taylor N, Wycuff D, Moore PL, Tomaras GD, Wibmer CK, Puren A, DeCamp A, Gilbert PB, Wood B et al..  2009.  Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.. Journal of virology. 83(17):8925-37. Abstract
2011
Letvin NL, Rao SS, Montefiori DC, Seaman MS, Sun Y, Lim S-Y, Yeh WW, Asmal M, Gelman RS, Shen L et al..  2011.  Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.. Science translational medicine. 3(81):81ra36. Abstract
Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, Lapedes AS, Shen T, Gaschen B, Krishnamoorthy M, Li H et al..  2011.  Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections.. PLoS pathogens. 7(9):e1002209. Abstract
2013
Liu MKP, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M et al..  2013.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.. The Journal of clinical investigation. 123(1):380-93. Abstract
2014
Sterrett S, Learn GH, Edlefsen PT, Haynes BF, Hahn BH, Shaw GM, Bar KJ.  2014.  Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users.. Open forum infectious diseases. 1(2):ofu056. Abstract
2015
Kell A, Stoddard M, Li H, Marcotrigiano J, Shaw GM, Gale M.  2015.  PAMP Recognition of Hepatitis C Virus Transmitted/founder Variants by RIG-I is dependent on U-Core length.. Journal of virology. Abstract
2016
Astronomo RD, Santra S, Ballweber-Fleming L, Westerberg KG, Mach L, Hensley-McBain T, Sutherland L, Mildenberg B, Morton G, Yates NL et al..  2016.  Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.. EBioMedicine. 14:97-111. Abstract